INmune Bio (INMB) Proxy Filing summary

Executive summary

• Supplement corrects a typographical error regarding the voting standard for Proposal 5 related to the Second Amended and Restated 2021 Stock Incentive Plan.

• All other information and proposals in the original proxy statement remain unchanged.

Voting matters and shareholder proposals

• Proposal 5 now requires the affirmative vote of the majority of shares cast on the proposal, not just those present in person or by proxy.

• Abstentions and broker non-votes will count toward quorum but not as votes for or against Proposal 5.

• Voting standards for Proposals 1–4 remain as previously stated.